NCT01073072

Brief Summary

This is a multicentric prospective randomized study comparing technique of tension-free repair with placement of a bovine pericardium bioprosthesis (Tutopatch® and Tutomesh®) to current conventional surgical techniques in potentially contaminated hernia repair and abdominal wall reconstruction. The hypothesis is that using Tutomesh® prostheses reduces the risk of postoperative complications at 30 days in the treatment of incisional hernias or complicated abdominal wall hernias (ref early complications) for potentially contaminated fields.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
134

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2009

Typical duration for phase_3

Geographic Reach
1 country

19 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 23, 2010

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
Last Updated

March 16, 2012

Status Verified

March 1, 2012

Enrollment Period

1.7 years

First QC Date

February 19, 2010

Last Update Submit

March 15, 2012

Conditions

Keywords

bovine pericardium bioprosthesiscontaminationhernia repairabdominal wall reconstructionTutomeshTutopatchPotentially Contaminated Hernia RepairPotentially Contaminated Abdominal Wall Reconstruction

Outcome Measures

Primary Outcomes (1)

  • risk of postoperative complications: occurrence of complications related to pathology or surgery will be evaluated with the report of adverse events and emergency visits

    30 days

Secondary Outcomes (4)

  • recurrence risk: Assessment of relapse thanks to emergency visits and to adverse events' report

    1 year

  • the impact on postoperative pain: Assessment of postoperative pain by postponing analgesics

    1 year

  • the socio-economic impact will be evaluated with the concomitant treatment and hospitalisations.

    1 year

  • the impact on patients' quality of life: The evaluation of patient's quality of life will be done with the questionnaire quality of life SF12

    1 year

Study Arms (2)

Tutomesh

EXPERIMENTAL

Technique of abdominal wall reconstruction strengthened by Tutomesh®

Procedure: Technique Tutomesh®

conventional repair

ACTIVE COMPARATOR

Conventional technique to repair incisional or abdominal wall hernias

Procedure: Conventional technique

Interventions

Conventional technique to repair potentially contaminated incisional or abdominal wall hernias

conventional repair

Technique of abdominal wall reconstruction or hernia repair strengthened by Tutomesh® in potentially contaminated environment.

Tutomesh

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient presenting with an incisional hernia or complicated hernia contraindicating the use of non absorbable mesh:
  • Infected incisional hernia: abdominal wall abscess, chronic fistula
  • Incisional hernia with high septic potential: incisional hernia with strangulation of one or more intestinal loops, repair of incisional hernia during surgery requiring opening of the digestive tube (digestive resection, restoration of digestive continuity, gastro-intestinal perforation, peritonitis from digestive origin)
  • Recurrent incisional hernia with problem of cutaneous healing
  • Incisional hernia requiring important intestinal adhesiolysis
  • Patients signing informed consent form after reading and understanding the information letter \_ Patients are more than 18 year old

You may not qualify if:

  • Patient with major anesthetic risk (ASA 4)
  • Patient suffering from immunodepression or under immunosuppressor treatment (corticoids…)
  • Patients already enrolled in another study
  • Patient suffering from severe disease not allowing a 1-year follow-up
  • Patient refusing to be enrolled after consulting the information letter
  • Patient presenting with a too large incisional hernia, superior to 140x200 mm
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (19)

CH Aix en Provence

Aix-en-Provence, 13616, France

Location

CHU Amiens

Amiens, 80054, France

Location

Ch Antibes-Juan les pins

Antibes, France

Location

Clinique de la Casamance

Aubagne, 13400, France

Location

CH Avignon

Avignon, 84900, France

Location

CHG Beziers

Béziers, 34525, France

Location

CHU Jean Verdier

Bondy, 93143, France

Location

CHU Fréjus

Fréjus, 83600, France

Location

CHU Grenoble

Grenoble - La Tronche, 38700, France

Location

Hôpital Nord

Marseille, 13915, France

Location

CH St Eloi

Montpellier, 34000, France

Location

CHU Nantes

Nantes, France

Location

CHU Archet II

Nice, 06202, France

Location

CH Nimes

Nîmes, France

Location

CHU Hôtel Dieu

Paris, 75004, France

Location

CH Salon de Provence

Salon-de-Provence, 13658, France

Location

CH Hautepierre

Strasbourg, 67200, France

Location

CHU Rangueil

Toulouse, 31059, France

Location

CHU Trousseau

Tours, 37000, France

Location

Study Officials

  • David Nocca, Dr

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. David NOCCA, CHRU Montpellier

Study Record Dates

First Submitted

February 19, 2010

First Posted

February 23, 2010

Study Start

January 1, 2009

Primary Completion

October 1, 2010

Study Completion

October 1, 2011

Last Updated

March 16, 2012

Record last verified: 2012-03

Locations